Thomas Ciulla is Chief Medical Officer of Clearside Biomedical Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Viridian Therapeutics, Inc.\DE
7 Feb 24
3
Viridian Therapeutics, Inc.\DE
12 Jan 24
4
Clearside Biomedical, Inc.
20 Jan 23
4
Clearside Biomedical, Inc.
11 Jan 23
4
Clearside Biomedical, Inc.
6 Jan 23
4/A
Clearside Biomedical, Inc.
28 Jan 22
4
Clearside Biomedical, Inc.
20 Jan 22
4
Clearside Biomedical, Inc.
23 Sep 21
4
Clearside Biomedical, Inc.
3 Mar 21
4
Clearside Biomedical, Inc.
20 Jan 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 24 | VRDN Viridian Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.7 | 50,000 | 935.00 k | 50,000 |
20 Jan 23 | CLSD Clearside Biomedical | Common Stock | Sell | Dispose S | No | Yes | 1.47 | 13,700 | 20.14 k | 291,890 |
10 Jan 23 | CLSD Clearside Biomedical | Common Stock | Sell | Dispose S | No | Yes | 1.62 | 2,170 | 3.52 k | 305,590 |
4 Jan 23 | CLSD Clearside Biomedical | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 187,500 | 277.50 k | 187,500 |
31 Dec 22 | CLSD Clearside Biomedical | Common Stock | Grant | Acquire A | No | No | 0.95 | 5,000 | 4.75 k | 307,760 |
30 Jun 22 | CLSD Clearside Biomedical | Common Stock | Grant | Acquire A | No | No | 1.25 | 5,000 | 6.25 k | 302,760 |